1. Home
  2. GPMT vs CLRB Comparison

GPMT vs CLRB Comparison

Compare GPMT & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

N/A

Current Price

$3.33

Market Cap

24.5M

Sector

Real Estate

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

N/A

Current Price

$1.25

Market Cap

24.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPMT
CLRB
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
24.5M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
GPMT
CLRB
Price
$3.33
$1.25
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$11.50
$11.50
AVG Volume (30 Days)
43.1K
★ 159.7K
Earning Date
11-04-2026
11-10-2026
Dividend Yield
★ 10.72%
N/A
EPS Growth
★ 73.58
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$308.40
N/A
Revenue Next Year
$9.66
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$1.12
52 Week High
$7.61
$4.70

Technical Indicators

Market Signals
Indicator
GPMT
CLRB
Relative Strength Index (RSI) 40.14 39.39
Support Level $1.39 N/A
Resistance Level $7.61 $3.40
Average True Range (ATR) 0.34 0.10
MACD -0.28 0.04
Stochastic Oscillator 0.85 50.00

Price Performance

Historical Comparison
GPMT
CLRB

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: